Medical Oncologist
Rare but serious side effects
Blood Cancer Risk After — Long-Term Olaparib
A risk of myelodysplastic syndrome (MDS) or acute myeloid leukaemia (AML) is associated with long-term olaparib. Most patients are not affected. Knowing which symptoms to report the same day, and which to mention at your next appointment, is the practical question this page answers.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed August 2026
- A real but rare risk — MDS and AML are listed in olaparib's approved prescribing information. Most patients taking olaparib long-term are not affected.
- Blood tests are your main protection — Regular monitoring catches early changes in blood counts before you feel unwell. Keeping all appointments matters.
- Symptoms overlap with common fatigue — Tiredness and breathlessness are common on olaparib for many reasons. Knowing which pattern needs same-day action is what this page covers.
- Do not stop olaparib without your team — Stopping without discussion removes cancer protection while the risk already accumulated from treatment remains. Talk to your oncologist if you are concerned.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
A small but real risk of myelodysplastic syndrome (MDS) or acute myeloid leukaemia (AML) is associated with long-term olaparib use, and is documented in EMA and FDA prescribing information. Most patients are not affected. Symptoms overlap with common treatment tiredness, so knowing which signs need urgent blood tests today is what matters.
Is this a risk you need to worry about every day?
MDS and AML are serious conditions, and your oncologist is right to make you aware of them. In daily life, what matters is knowing what to watch for and keeping your scheduled blood tests.
Your blood counts are checked regularly on olaparib precisely because early changes show up in results before you feel unwell. That monitoring is your main protection. Missing a blood test appointment matters more than any individual symptom.
If you notice you are more tired than before, more breathless than last week, or bruising more easily, mention it at your next appointment or sooner if it is worrying you. These symptoms on their own do not need the emergency department, but they should not be ignored.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
How do you tell expected tiredness from a warning sign?
| Feature | Common on olaparib — expected | Possible blood count problem — tell your team |
|---|---|---|
| Tiredness | Manageable, improves with rest, stable week to week | Getting noticeably worse each week, stops you doing things you could manage before |
| Breathlessness | Mild on exertion, stable or slowly improving | New breathlessness at rest, or worsening with less effort than before |
| Bruising or bleeding | Not a typical olaparib side effect | Unexplained bruising, or any bleeding not caused by injury |
| Skin spots | Mild rash — report to your team, not urgent | Tiny red or purple pinpoint spots (petechiae) on skin or inside the mouth |
| Infections | No more than usual | Repeated infections, slow to clear, or fever without an obvious cause |
| Typically starts | Fatigue and nausea often begin in the first weeks | Blood count changes usually develop months to years into treatment, most often found on routine testing |
What families ask most about this risk
How rare is MDS or leukaemia on olaparib, really?
The risk is real and is listed prominently in olaparib's prescribing information approved by both the EMA and the US FDA. It affects a minority of patients in clinical trials, and those trials enrolled patients who had often also received prior chemotherapy, which itself carries a long-term blood cancer risk. Untangling whether MDS arises from olaparib, from prior treatment, or from the interaction of both is genuinely difficult. What regulators concluded is that the risk is significant enough to monitor for throughout treatment.
Does olaparib cause this, or was I already at risk?
Almost certainly both. PARP inhibitors put a particular kind of stress on DNA repair in bone marrow cells. Prior platinum-based chemotherapy also raises the long-term risk of MDS and AML independently of olaparib. Many patients starting olaparib have already had platinum chemotherapy, meaning their background risk was already somewhat elevated before olaparib began. Your oncologist weighed that background risk against the substantial benefit olaparib offers before recommending it for you.
Will blood tests always catch this before I feel ill?
Usually, yes. MDS tends to show up as gradually falling blood counts well before symptoms become obvious, which is exactly what regular monitoring is designed to detect. AML can behave differently and sometimes progresses quickly, which is why unexplained fever, new bleeding, or sudden severe worsening of fatigue should not wait for a scheduled appointment but should prompt a same-day call. Keeping all your blood test appointments is the most useful thing you can do throughout your time on olaparib.
If early MDS is found, does olaparib have to stop?
Not automatically. If a change in blood counts is found, your team will assess how significant it is and whether it is progressing. Mild unexplained changes are investigated before any conclusion is drawn. If MDS is confirmed, whether to continue, pause or stop olaparib depends on how severe the blood condition is and how much benefit olaparib is still providing. That is a conversation your oncologist will have with you based on your individual results — there is no single answer that applies to all patients.
Should I stop olaparib because of this risk?
No, not without talking to your oncologist. Olaparib is prescribed because its benefit in controlling your cancer is judged to outweigh its risks, including this one. Stopping without discussion removes cancer protection while the risk that has already accumulated from treatment remains. If this worry is significant enough that you are considering stopping, that is exactly the conversation to have with your team — not a decision to make alone at home.
Explore 75 more Kidney, Ovarian & Sarcoma Targeted Medicines topics
Drug Deep Dive: Olaparib (Lynparza)
- Adjuvant Olaparib After Early Breast Cancer Surgery
- Anaemia and Extreme Fatigue on Olaparib
- Blood Cancer Risk After Long-Term Olaparib: How Real Is It?
- Diet and Nutrition While on Olaparib
- Drug, Food and Supplement Interactions With Olaparib
- Fertility, Pregnancy and Contraception on Olaparib
- How Does Olaparib Work? The PARP Inhibitor Explained
- How Long Does Olaparib Take to Work?
- How Long Will You Stay on Olaparib?
- Maintenance Olaparib: Taking a Drug When There Is No Visible Cancer
- Nausea on Olaparib: Managing the Most Common Side Effect
- Olaparib (Lynparza, Olanib): The Complete Patient Guide
- Olaparib Myths: 'Only for BRCA', 'It's Chemo', 'It Causes Cancer'
- Olaparib Price in India: Brand, Generic and Monthly Cost
- Olaparib Side Effects: The Complete List and Timeline
- Olaparib Success Rate and Survival: An Honest Look at the Numbers
- Olaparib With Bevacizumab or Hormone Therapy: Combination Regimens
- Olaparib in Elderly Patients and Those With Other Illnesses
- Olaparib vs Niraparib vs Talazoparib: Comparing PARP Inhibitors
- Taking Olaparib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Olaparib
- When Olaparib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Olaparib? BRCA-Mutated Ovarian, Breast, Prostate and Pancreatic Cancer
- Will Insurance or a Government Scheme Pay for Olaparib?
- Work, Travel and Daily Life on Olaparib
Drug Deep Dive: Pazopanib (Votrient)
- Diarrhoea and Blood Pressure Rise on Pazopanib
- Diet and Nutrition While on Pazopanib
- Drug, Food and Supplement Interactions With Pazopanib
- Fertility, Pregnancy and Contraception on Pazopanib
- Hair Turning White and Skin Lightening on Pazopanib
- How Does Pazopanib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Pazopanib Take to Work?
- How Long Will You Stay on Pazopanib?
- Liver Toxicity on Pazopanib: Why LFTs Are Checked Every Two Weeks
- Pazopanib (Votrient, Pazonib): The Complete Patient Guide
- Pazopanib Combinations: Why It Is Usually Given Alone
- Pazopanib Myths: Hair Colour, Liver Damage and Stopping Early
- Pazopanib Price in India: Brand, Generic and Monthly Cost
- Pazopanib Side Effects: The Complete List and Timeline
- Pazopanib Success Rate and Survival: An Honest Look at the Numbers
- Pazopanib for Soft Tissue Sarcoma: What It Can and Cannot Do
- Pazopanib in Elderly Patients and Those With Other Illnesses
- Pazopanib in Kidney Cancer vs Sarcoma: Two Different Treatment Goals
- Pazopanib vs Sunitinib: Comparing Toxicity and Quality of Life
- Taking Pazopanib on an Empty Stomach: Why the Timing Rule Exists
- Tests and Monitoring While You Are on Pazopanib
- When Pazopanib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Pazopanib? Kidney Cancer and Soft Tissue Sarcoma
- Will Insurance or a Government Scheme Pay for Pazopanib?
- Work, Travel and Daily Life on Pazopanib
Drug Deep Dive: Sunitinib (Sutent)
- Diet and Nutrition While on Sunitinib
- Drug, Food and Supplement Interactions With Sunitinib
- Fertility, Pregnancy and Contraception on Sunitinib
- Hand-Foot Skin Reaction on Sunitinib: Prevention From Day One
- How Does Sunitinib Work? The Multi-Kinase Angiogenesis Inhibitor Explained
- How Long Does Sunitinib Take to Work?
- How Long Will You Stay on Sunitinib?
- Mouth Sores, Taste Loss and Yellow Skin Discolouration on Sunitinib
- Sunitinib (Sutent, Sunitix): The Complete Patient Guide
- Sunitinib After Kidney Surgery and for GIST: Two Different Settings
- Sunitinib Myths: Hair Colour Change, Dose Cuts and 'Weaker Treatment'
- Sunitinib Price in India: Brand, Generic and Monthly Cost
- Sunitinib Side Effects: The Complete List and Timeline
- Sunitinib Success Rate and Survival: An Honest Look at the Numbers
- Sunitinib and Immunotherapy: Where Combinations Fit in Kidney Cancer
- Sunitinib in Elderly Patients and Those With Other Illnesses
- Sunitinib vs Pazopanib vs Cabozantinib for Kidney Cancer
- Taking Sunitinib: Food, Timing and What to Do If You Miss a Dose
- Tests and Monitoring While You Are on Sunitinib
- The 4-Weeks-On, 2-Weeks-Off Sunitinib Schedule and the 2/1 Alternative
- Thyroid Failure and Fatigue on Sunitinib: The Test to Repeat Every Cycle
- When Sunitinib Stops Working: Resistance and What Comes Next
- Who Is Eligible for Sunitinib? Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumours
- Will Insurance or a Government Scheme Pay for Sunitinib?
- Work, Travel and Daily Life on Sunitinib
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Which symptoms should make me call today rather than wait for my next appointment?
Call the same day if you have unexplained fever, new or worsening breathlessness, bruising without injury, or tiny red or purple spots on your skin. These are not symptoms to watch at home for a few days. Tiredness that is slowly getting worse over weeks, or slightly more breathlessness than before, can be mentioned at your next appointment — but ask at that visit whether a blood test sooner would be sensible.
How often are blood tests done while I am on olaparib?
Blood counts are checked at intervals set by your oncologist, most commonly before each cycle or at regular intervals during long-term treatment. The schedule may change if earlier results gave reason for closer monitoring. If you are unsure when your next test is due, ask your team. Missing tests because you feel well is one of the most common ways early changes are detected later than they could have been.
What is MDS and how is it different from leukaemia?
Myelodysplastic syndrome (MDS) is a condition where the bone marrow produces blood cells that are abnormal or insufficient in number. It is sometimes called a pre-leukaemia, but many people with MDS never develop leukaemia. Acute myeloid leukaemia (AML) is a faster-moving blood cancer where the bone marrow is overwhelmed by abnormal immature cells. Both are detectable through blood counts and, when needed, bone marrow tests — which is why monitoring continues throughout olaparib treatment.
Is there anything I can do at home to reduce this risk?
There is no proven way to reduce the underlying risk through diet, supplements or lifestyle changes. The monitoring schedule your team has set is your active protection — keeping those appointments is what matters most. Tell your team about any traditional preparations, supplements or over-the-counter medicines you are taking, because some affect blood counts. Reporting new symptoms promptly means any change is investigated early, when it is most manageable.
If MDS or AML is diagnosed while I am on olaparib, what happens next?
You would be referred to a haematologist, and decisions about both the blood condition and your olaparib would be made together. Whether to pause or stop olaparib depends on the type and severity of the blood condition, your age, fitness and overall medical picture — not a fixed rule. Treatment for MDS or AML has its own range of options and is decided based on your individual situation. Being on olaparib does not mean the blood condition cannot be treated.